7-May-2025 3:13 PM CST - Business Wire GoodRx Reports First Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025. First Quarter 2025 Highlights Revenue of $203.0 million Net income of $11.1 million; Net income margin of 5.4% Adjusted Net Income1 of $34.4 million; Adjusted Net Income Margin1 of 16.9% Adjusted EBITDA1 of $69.8 million; Adjusted EBITDA Margin1 of 34
9-Apr-2025 3:05 PM CST - Business Wire GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close on Wednesday, May 7, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 8, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys business out
27-Feb-2025 5:05 AM CST - Business Wire GoodRx Reports Fourth Quarter and Full Year 2024 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading prescription savings platform in the U.S., has released its financial results for the fourth quarter and full year of 2024. Fourth Quarter 2024 Highlights Revenue1 of $198.6 million Net income of $6.7 million; Net income margin of 3.4% Adjusted Net Income1 of $34.7 million; Adjusted Net Income Margin1 of 17.5% Adjusted EBITDA1 of $67.1 million; Adjusted EBITDA
30-Jan-2025 3:05 PM CST - Business Wire GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial results before U.S. markets open on Thursday, February 27, 2025. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys business outlook. To acces
18-Dec-2024 3:05 PM CST - Business Wire GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time). A live webcast will be available on the Company's Investor Relations website, https://investors.
7-Nov-2024 5:05 AM CST - Business Wire GoodRx Reports Third Quarter 2024 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024. Third Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $195.3 million Net income of $4.0 million; Net income margin of 2.0% Adjusted Net Income1 of $31.9 million; Adjusted Net Income Margin1 of 16.4% Adjusted EBITDA1 of $65.0 million; Adjusted
4-Nov-2024 3:05 PM CST - Business Wire GoodRx to Participate in Upcoming Investor Conferences GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: UBS 2024 Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 12, 2024 at 2 p.m. Eastern Time (11 a.m. Pacific Time) Citi 2024 Global Healthcare Conference in Miami, FL, on Thursday,
10-Oct-2024 4:41 PM CST - Business Wire GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, November 7, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys business outlook. To access the conference
7-May-2025 3:13 PM CST - Business Wire GoodRx Reports First Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025. First Quarter 2025 Highlights Revenue of $203.0 million Net income of $11.1 million; Net income margin of 5.4% Adjusted Net Income1 of $34.4 million; Adjusted Net Income Margin1 of 16.9% Adjusted EBITDA1 of $69.8 million; Adjusted EBITDA Margin1 of 34
9-Apr-2025 3:05 PM CST - Business Wire GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close on Wednesday, May 7, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 8, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys business out
27-Feb-2025 5:05 AM CST - Business Wire GoodRx Reports Fourth Quarter and Full Year 2024 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading prescription savings platform in the U.S., has released its financial results for the fourth quarter and full year of 2024. Fourth Quarter 2024 Highlights Revenue1 of $198.6 million Net income of $6.7 million; Net income margin of 3.4% Adjusted Net Income1 of $34.7 million; Adjusted Net Income Margin1 of 17.5% Adjusted EBITDA1 of $67.1 million; Adjusted EBITDA
30-Jan-2025 3:05 PM CST - Business Wire GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial results before U.S. markets open on Thursday, February 27, 2025. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys business outlook. To acces
18-Dec-2024 3:05 PM CST - Business Wire GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time). A live webcast will be available on the Company's Investor Relations website, https://investors.
7-Nov-2024 5:05 AM CST - Business Wire GoodRx Reports Third Quarter 2024 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024. Third Quarter 2024 Highlights Revenue1 and Adjusted Revenue1 of $195.3 million Net income of $4.0 million; Net income margin of 2.0% Adjusted Net Income1 of $31.9 million; Adjusted Net Income Margin1 of 16.4% Adjusted EBITDA1 of $65.0 million; Adjusted
4-Nov-2024 3:05 PM CST - Business Wire GoodRx to Participate in Upcoming Investor Conferences GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: UBS 2024 Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 12, 2024 at 2 p.m. Eastern Time (11 a.m. Pacific Time) Citi 2024 Global Healthcare Conference in Miami, FL, on Thursday,
10-Oct-2024 4:41 PM CST - Business Wire GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, November 7, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys business outlook. To access the conference
